"Abandoning the Notion of Non-Small Cell Lung Cancer”
Relli V., Trerotola M., Guerra E., Alberti S. Trends Mol Med. 2019 May 30.
“Distinct lung cancer subtypes associate to distinct drivers of tumor progression”
Relli V., Trerotola M., Guerra E., Alberti S. Oncotarget. 2018 Oct 30.
“Trop-2 induces tumor growth through Akt and determines sensitivity to Akt inhibitors”
Guerra E., Trerotola M., Tripaldi R., Aloisi AL., Simeone P., Sacchetti A., Relli V., D’ Amore A., La Sorda R., Lattanzio R., Piantelli M. and Alberti S. Clinical Cancer Research. 2016.
“Epigenetic inheritance and the missing heritability”
Trerotola M.,Relli V., Simeone P., Alberti S. Human Genomics. 2015 Jul 28; 9:17.
“Trop-2 is a determinant of breast cancer survival”
Ambrogi F., Fornili M., Boracchi P.,Trerotola M., Relli V. et all. PLoS ONE. 2014 May 13; 8(5).
“Novel anti-Trop-2 monoclonal antibodies with unique binding specificities show therapeutic synergy against most human cancers”
E. Guerra, M.Trerotola, V. Relli, C. Pedicone, A. D' Amore, F. Dini, S. Fratarcangeli, S. Alberti. Cancer Research July 1 2017 (77) (13 Supplement) 4588. AACR Annual Meeting 2017; Washington.
“Novel domain-targeted anti-Trop2 monoclonal antibodies show therapeutic synergy against multiple human cancers”
S. Alberti, M. Trerotola, V. Relli, C. Pedicone, A. D' Amore, F. Dini, S. Fratarcangeli, E. Guerra Journal of Clinical Oncology. 2017
“Trop-2 activates a dormant Na /K ATPase/ PKCα/CD9/ezrin signaling axis to override the basal growth program of cancer cells”
M.Trerotola, V. Relli, R. Tripaldi, A. Sacchetti, K. Havas, P. Simeone, E. Guerra, A. Aloisi, R. La Sorda, R. Lattanzio, D. Vergara, I. Fournier, M. Salzet, M. Piantelli, S. Alberti
Cancer Research July 1 2017 (77) (13 Supplement) 367. AACR Annual Meeting 2017; Washington.
“Identification of cancers stem cells in triple negative phenotype of breast carcinoma: comparison between different CSCS markers”
M. Di Bonito, F. Collina, G. Scognamiglio, M. D’Aiuto, A. Manna, V. Relli, L. La Sala, G. Liguori, M. Cantile, G. Botti. Pathologica 2012.
“B-cell clonality and CD20 expression in classical Hodgkin Lymphoma”
L. Marra, M. Cerrone, V. Gigantino, G. Aquino, F. Tisci; V. Relli, L. La Sala, C. Santonastaso, A.R. De Chiaa, R. Franco, G. Botti. Pathologica 2012.
“Sparc expression in lung metastases from different human tumors: an IHC study realized on a Tissue MicroArray and supported by gene expression analysis”
F. Zito Marino, G. Scognamiglio, F. Collina, E. La Mantia, G. Aquino, G. Gaudioso, V. Relli, R. Sabatino, M. Cantile, R. Franco, G.Botti. Pathologica 2012
“Hyperexpression of HOX C13 in melanoma progression”
G.Scognamiglio, A.Anniciello, L.Marra, M.Farina, O.Sacco, V.Relli, A.Pelella, G.Aquino, G.Liguori, M. Cantile, R.Franco, G.Botti. BIOBANK FOR CANCER RESEARCH:RULES AND ROLES 12-13 Novembre 2010
“CD90 expression in meningiomas”
E.La Mantia, G. Scognamiglio, V.Relli, G.Rossi, L. Sparano, A.Mirabella, R.Franco, G.Rocco,G. Botti.
Pathologica 2011.
“MHC class I molecule delocalization and deregulation in melanoma metastases”
G. Scognamiglio, A.Anniciello, A. Barbato, M.Farina, V.Relli, M. Cerrone, R.Franco, G.Botti. Pathologica 2011.
